Literature DB >> 12134068

Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake.

Aimee L Edinger1, Craig B Thompson.   

Abstract

In multicellular organisms, constituent cells depend on extracellular signals for growth, proliferation, and survival. When cells are withdrawn from growth factors, they undergo apoptosis. Expression of constitutively active forms of the serine/threonine kinase Akt/PKB can prevent apoptosis upon growth factor withdrawal. Akt-mediated survival depends in part on the maintenance of glucose metabolism, suggesting that reduced glucose utilization contributes to growth factor withdrawal-induced death. However, it is unclear how restricting access to extracellular glucose alone would lead to the metabolic collapse observed after growth factor withdrawal. We report herein that growth factor withdrawal results in the loss of surface transporters for not only glucose but also amino acids, low-density lipoprotein, and iron. This coordinated decline in transporters and receptors for extracellular molecules creates a catabolic state characterized by atrophy and a decline in the mitochondrial membrane potential. Activated forms of Akt maintained these transporters on the cell surface in the absence of growth factor through an mTOR-dependent mechanism. The mTOR inhibitor rapamycin diminished Akt-mediated increases in cell size, mitochondrial membrane potential, and cell survival. These results suggest that growth factors control cellular growth and survival by regulating cellular access to extracellular nutrients in part by modulating the activity of Akt and mTOR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134068      PMCID: PMC117312          DOI: 10.1091/mbc.01-12-0584

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  49 in total

Review 1.  Growth factor signaling in cell survival: implications for cancer treatment.

Authors:  S Talapatra; C B Thompson
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

Review 2.  The target of rapamycin (TOR) proteins.

Authors:  B Raught; A C Gingras; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

Review 3.  Molecular biology of mammalian plasma membrane amino acid transporters.

Authors:  M Palacín; R Estévez; J Bertran; A Zorzano
Journal:  Physiol Rev       Date:  1998-10       Impact factor: 37.312

4.  Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest.

Authors:  J M Garland; A Halestrap
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

5.  Growth factors can influence cell growth and survival through effects on glucose metabolism.

Authors:  M G Vander Heiden; D R Plas; J C Rathmell; C J Fox; M H Harris; C B Thompson
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice.

Authors:  K Podsypanina; R T Lee; C Politis; I Hennessy; A Crane; J Puc; M Neshat; H Wang; L Yang; J Gibbons; P Frost; V Dreisbach; J Blenis; Z Gaciong; P Fisher; C Sawyers; L Hedrick-Ellenson; R Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

7.  Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

Authors:  M S Neshat; I K Mellinghoff; C Tran; B Stiles; G Thomas; R Petersen; P Frost; J J Gibbons; H Wu; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

Review 8.  The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.

Authors:  M Hidalgo; E K Rowinsky
Journal:  Oncogene       Date:  2000-12-27       Impact factor: 9.867

Review 9.  Endocytosis proteins and cancer: a potential link?

Authors:  S Floyd; P De Camilli
Journal:  Trends Cell Biol       Date:  1998-08       Impact factor: 20.808

10.  Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway.

Authors:  P H Scott; G J Brunn; A D Kohn; R A Roth; J C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more
  223 in total

Review 1.  The influence of cell volume changes on tumour cell proliferation.

Authors:  Jean-Marc Dubois; Béatrice Rouzaire-Dubois
Journal:  Eur Biophys J       Date:  2003-11-04       Impact factor: 1.733

2.  RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development.

Authors:  Irit Adini; Isaac Rabinovitz; Jing Fang Sun; George C Prendergast; Laura E Benjamin
Journal:  Genes Dev       Date:  2003-11-01       Impact factor: 11.361

Review 3.  Heart mitochondria signaling pathways: appraisal of an emerging field.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  J Mol Med (Berl)       Date:  2004-06-23       Impact factor: 4.599

4.  TFEB, a novel mTORC1 effector implicated in lysosome biogenesis, endocytosis and autophagy.

Authors:  Samuel Peña-Llopis; James Brugarolas
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

Review 5.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

6.  Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation.

Authors:  Erikka L Carr; Alina Kelman; Glendon S Wu; Ravindra Gopaul; Emilee Senkevitch; Anahit Aghvanyan; Achmed M Turay; Kenneth A Frauwirth
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

7.  Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways.

Authors:  Seong M Kim; Saurabh G Roy; Bin Chen; Tiffany M Nguyen; Ryan J McMonigle; Alison N McCracken; Yanling Zhang; Satoshi Kofuji; Jue Hou; Elizabeth Selwan; Brendan T Finicle; Tricia T Nguyen; Archna Ravi; Manuel U Ramirez; Tim Wiher; Garret G Guenther; Mari Kono; Atsuo T Sasaki; Lois S Weisman; Eric O Potma; Bruce J Tromberg; Robert A Edwards; Stephen Hanessian; Aimee L Edinger
Journal:  J Clin Invest       Date:  2016-09-26       Impact factor: 14.808

8.  Rapid hepatocyte nuclear translocation of the Forkhead Box M1B (FoxM1B) transcription factor caused a transient increase in size of regenerating transgenic hepatocytes.

Authors:  Xinhe Wang; Dibyendu Bhattacharyya; Margaret B Dennewitz; Vladimir V Kalinichenko; Yan Zhou; Rita Lepe; Robert H Costa
Journal:  Gene Expr       Date:  2003

9.  Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival.

Authors:  Jeffrey C Rathmell; Casey J Fox; David R Plas; Peter S Hammerman; Ryan M Cinalli; Craig B Thompson
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 10.  Metabolic Regulation of Apoptosis in Cancer.

Authors:  K Matsuura; K Canfield; W Feng; M Kurokawa
Journal:  Int Rev Cell Mol Biol       Date:  2016-07-30       Impact factor: 6.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.